ONCE-YEARLY SUPPRELIN LA (HISTRELIN ACETATE) SUBCUTANEOUS IMPLANT

Serial Number 85354181
Registration 4105047
710

Registration Progress

Application Filed
Jun 23, 2011
Under Examination
Approved for Publication
Dec 13, 2011
Published for Opposition
Dec 13, 2011
Registered
Feb 28, 2012

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ONCE-YEARLY SUPPRELIN LA (HISTRELIN ACETATE) SUBCUTANEOUS IMPLANT
Previous Owner: Endo Pharmaceuticals Solutions Inc.

Trademark Image

ONCE-YEARLY SUPPRELIN LA (HISTRELIN ACETATE) SUBCUTANEOUS IMPLANT

Basic Information

Serial Number
85354181
Registration Number
4105047
Filing Date
June 23, 2011
Registration Date
February 28, 2012
Published for Opposition
December 13, 2011
Cancellation Date
September 9, 2022
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Sep 9, 2022

Rights Holder

Endo Pharmaceuticals Solutions Inc.

03
Address
1400 Atwater Drive
Malvern, PA 19355

Ownership History

Endo Pharmaceuticals Solutions Inc.

Original Applicant
03
Chadds Ford, PA

Endo Pharmaceuticals Solutions Inc.

Owner at Publication
03
Chadds Ford, PA

Endo Pharmaceuticals Solutions Inc.

Original Registrant
03
Malvern, PA

Legal Representation

Attorney
Camille M. Miller

USPTO Deadlines

Next Deadline
2255 days remaining
Section 8 & 9 Renewal Due (Principal Register) (20-Year) (Based on R.PRA event 2012-02-28)
Due Date
February 28, 2032
Grace Period Ends
August 28, 2032

Application History

27 events
Date Code Type Description Documents
Jun 28, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Sep 9, 2022 CAEX O CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Loading...
Dec 22, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Feb 28, 2021 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 3, 2017 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 3, 2017 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 3, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 18, 2017 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Feb 28, 2017 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 25, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 25, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 26, 2014 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Feb 28, 2012 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 13, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 13, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 23, 2011 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 9, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 9, 2011 ALIE A ASSIGNED TO LIE Loading...
Oct 18, 2011 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 18, 2011 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 18, 2011 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 18, 2011 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 18, 2011 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 6, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 30, 2011 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Jun 29, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 27, 2011 NWAP I NEW APPLICATION ENTERED Loading...

Additional Information

Design Mark
The mark consists of the words "ONCE-YEARLY" in purple, "SUPPRELIN" in aqua, "LA (histrelin acetate) subcutaneous implant" in pink. To the left of the words is a stylized graphic of a child figure in the midst of a cart wheel. The figure is shown in skin tone, pink pants and aqua and red top with brown hair.
Color Claim
The color(s) purple, aqua, pink, red, brown and skin tone is/are claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ONCE-YEARLY SUPPRELIN LA (HISTRELIN ACETATE) SUBCUTANEOUS IMPLANT"